Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 211

1.

Management of recurrent depression.

Kupfer DJ.

J Clin Psychiatry. 1993 Feb;54 Suppl:29-33; discussion 34-5. Review.

PMID:
8444832
2.

Efficacy in long-term treatment of depression.

Montgomery SA.

J Clin Psychiatry. 1996;57 Suppl 2:24-30. Review.

PMID:
8626360
3.

Guidelines for the long-term treatment of depression.

Hirschfeld RM.

J Clin Psychiatry. 1994 Dec;55 Suppl:61-9; discussion 70-1. Review.

PMID:
7814359
4.

Three-year outcomes for maintenance therapies in recurrent depression.

Frank E, Kupfer DJ, Perel JM, Cornes C, Jarrett DB, Mallinger AG, Thase ME, McEachran AB, Grochocinski VJ.

Arch Gen Psychiatry. 1990 Dec;47(12):1093-9.

PMID:
2244793
5.

The expert consensus guideline series. Pharmacotherapy of depressive disorders in older patients.

Alexopoulos GS, Katz IR, Reynolds CF 3rd, Carpenter D, Docherty JP; Expert Consensus Panel for Pharmacotherapy of Depressive Disorders in Older Patients..

Postgrad Med. 2001 Oct;Spec No Pharmacotherapy:1-86.

PMID:
17205639
6.

Long-term management of depression.

Hirschfeld RM, Schatzberg AF.

Am J Med. 1994 Dec 19;97(6A):33S-38S. Review.

PMID:
7992825
7.

Selective serotonin reuptake inhibitor discontinuation syndrome: a randomized clinical trial.

Rosenbaum JF, Fava M, Hoog SL, Ascroft RC, Krebs WB.

Biol Psychiatry. 1998 Jul 15;44(2):77-87.

PMID:
9646889
8.

A double-blind study of long-term treatment with sertraline or fluvoxamine for prevention of highly recurrent unipolar depression.

Franchini L, Gasperini M, Perez J, Smeraldi E, Zanardi R.

J Clin Psychiatry. 1997 Mar;58(3):104-7.

PMID:
9108811
9.

Long-term treatment of depression.

Montgomery SA.

Br J Psychiatry Suppl. 1994 Dec;(26):31-6. Review.

PMID:
7873135
10.

Antidepressant pharmacotherapy: economic evaluation of fluoxetine, paroxetine and sertraline in a health maintenance organization.

Sclar DA, Robison LM, Skaer TL, Galin RS, Legg RF, Nemec NL, Hughes TE, Buesching DP, Morgan M.

J Int Med Res. 1995 Nov-Dec;23(6):395-412.

PMID:
8746607
11.

The influence of different relapse criteria on the assessment of long-term efficacy of sertraline.

Montgomery SA, Doogan DP, Burnside R.

Int Clin Psychopharmacol. 1991 Dec;6 Suppl 2:37-46. Review.

PMID:
1806629
12.

Sertraline. A pharmacoeconomic evaluation of its use in depression.

Davis R, Wilde MI.

Pharmacoeconomics. 1996 Oct;10(4):409-31. Review.

PMID:
10184609
13.

Five-year outcome for maintenance therapies in recurrent depression.

Kupfer DJ, Frank E, Perel JM, Cornes C, Mallinger AG, Thase ME, McEachran AB, Grochocinski VJ.

Arch Gen Psychiatry. 1992 Oct;49(10):769-73.

PMID:
1417428
14.

Long-term treatment of depression.

Kupfer DJ.

J Clin Psychiatry. 1991 May;52 Suppl:28-34. Review.

PMID:
1903134
15.

Redefining antidepressant efficacy toward long-term recovery.

Thase ME.

J Clin Psychiatry. 1999;60 Suppl 6:15-9.

16.

Depression: a long-term illness and its treatment.

Montgomery SA, Kasper S.

Int Clin Psychopharmacol. 1998 Jul;13 Suppl 6:S23-6. Review.

PMID:
9728671
17.

The role of sertraline in the management of depression.

Shelton RC.

Clin Ther. 1994 Sep-Oct;16(5):768-82; discussion 767. Review.

PMID:
7859236
18.

A double-blind comparison of paroxetine with imipramine in the long-term treatment of depression.

Claghorn JL, Feighner JP.

J Clin Psychopharmacol. 1993 Dec;13(6 Suppl 2):23S-27S.

PMID:
8106652
19.

Strategies and tactics in the treatment of chronic depression.

Rush AJ, Thase ME.

J Clin Psychiatry. 1997;58 Suppl 13:14-22. Review.

20.

Tricyclic antidepressant and selective serotonin reuptake inhibitors antidepressant selection and health care costs in the naturalistic setting: a multivariate analysis.

Hylan TR, Crown WH, Meneades L, Heiligenstein JH, Melfi CA, Croghan TW, Buesching DP.

J Affect Disord. 1998 Jan;47(1-3):71-9.

PMID:
9476746
Items per page

Supplemental Content

Support Center